Contact Your Financial Adviser Money Making MC
26
November 2018
The
major indices of the Indian stock markets rallied on Monday and closed with
gains over Friday’s close. On the NSE, there were 681 advances, 1,033 declines
and 359 unchanged. The trends of the major indices in the course of Monday’s
trading are given in the table below:
India's
benchmark stock indices advanced about 1% on Monday, as investors stepped up
equity purchases after a string of declines last week. Firm Asian cues, and a
persistent decline in global crude oil prices also buoyed investor sentiment,
sending the Sensex over 370 points higher, while the broader Nifty topped the
10,600-mark. Buying was witnessed in the FMCG (fast moving consumer goods) and
consumer durables stocks. The index pivotals -- finance and banking -- were
1.32% and 1% higher, respectively. Export-oriented stocks like IT (information
technology) gained, while the healthcare traded lower. The overall market
breadth was negative, with 1,067 stocks advancing and 1,536 declining on
account of a 0.15% fall in the small-caps.
Crude
oil prices traded at $59.74 per barrel while the domestic currency stood at
Rs70.55 per dollar from its previous close of 70.67. Global crude oil price has
guided the markets for the past few weeks after it touched $86-a-barrel mark in
early October. The Brent crude oil slipped below $60 in just a month following
the US move to let eight countries, including India and China, continue buying
oil for six months from Iran despite its sanctions.
As
part of their retail network expansion plan, India's three state-run oil-marketing
companies would open 5,125 petrol bunks in Tamil Nadu over the next two years,
said a senior official of Indian Oil Corporation (IOC) on Sunday. IOC shares
closed at Rs137.45, down 0.61% on the BSE.
HEG
reported that its Board approved a proposal to buy back upto 13.63 lakh shares
(3.41%) of the company for an aggregate amount not exceeding Rs750 crore at a
price of Rs5,500 per equity share. HEG shares closed at Rs4,360.40, up 0.22% on
the BSE.
Lupin
has received approval for its Clomipramine HCl Capsules USP, a generic version
of SpecGx's Anafranil Capsules, from the US FDA. It is indicated for the
treatment of obsessions and compulsions in patients with OCD. Lupin has also
received approval for its Potassium Chloride for Oral Solution USP, 20 mEq from
the US FDA. It is indicated for the treatment and prophylaxis of
hypokalemia with or without metabolic alkalosis. Lupin shares closed at
Rs844.80, down 0.71% on the BSE.
Godrej
Properties and Godrej Fund Management have entered into a joint venture (JV)
agreement with Hero Cycles to develop a prime office development on Golf Course
Road, Gurgaon. The JV will develop, lease, and manage 1 Mn Sq.Ft of prime
office and retail space on the 4 acre property. Godrej Properties shares closed
at Rs671.35, up 2.93% on the BSE.
Aleor
Dermaceuticals, a subsidiary of Alembic Pharmaceuticals, received USFDA
approval for its ANDA for Lidocaine Ointment USP, 5%. It is indicated for
production of anesthesia of accessible mucous membranes of the oropharynx.
Alembic Pharma shares closed at Rs557.00, down 0.53% on the BSE.
Glenmark
Pharma has been granted tentative approval by the U.S. FDA for Clobetasol
Propionate Foam, a generic version of Olux-E®1 Foam of Mylan Pharma. The
company’s shares closed at Rs640.60, up 0.43% on the BSE.
The
top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices
are given in the table below: The Total
Investment & Insurance Solutions
 |
Major Indices (The Total
Investment & Insurance Solutions)
No comments:
Post a Comment